Carlyle’s Abingworth closes life sciences fund at $356m
Carlyle’s Abingworth has closed its Clinical Co-Development Co-Investment Fund (CCD CIF) at $356m.
The life sciences investment fund was oversubscribed from its existing investor base and welcomed new investors from the...